Treatment and prophylaxis for tumor Lysis syndrome

摘要

Claim 1: a Therapeutic or prophylactic agent for tumour lysis Syndrome, which comprises as an active ingredient a compound 2 - feniltiazol represented by formula (1), where: ru00b9 represents an alkoxy Group cu2081u208bu2088 morpholino, a Group, a group metilpiperazin - 4 - 1 - ILO,Or a piperidino Group; a represents a group Ru00b2 Nitro or cyano Group; X represents a carboxyl group or a Group alcoxicarbonilo cu2082u208bu2087; and y represents a hydrogen Atom or an alkyl group cu2081u208bu2086; or its pharmaceutically acceptable Salt.Claim 1: The therapeutic agent or prophylactic according to any one of claims 1 to 12, where the 2 - feniltiazol Compound represented by formula (1) above is acid, 2 - [3 - cyano - 4 - (2-methylpropoxy) phenyl - 4 - 5 - metilazol carboxylic acid or its Salt pharmaceutically accepted Ble.